合成低分子APIの市場規模、シェア、動向分析レポート：メーカー別（自社、アウトソース）、用途別（循環器、がん）、地域別、セグメント別予測、2022年～2030年

合成低分子API市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の合成低分子API市場規模は2030年までに2171億7000万米ドルに達すると予測されています。同市場は、2022年から2030年にかけて5.73%のCAGRを記録すると予測されています。これは、医薬品や低分子ベースの新薬に対する需要が世界的に高まっていることに起因しています。さらに、低分子APIは剤形間の汎用性があり、精製が容易なため、より受け入れられやすく、需要が高まっています。

製薬業界では合成医薬品の比率が高まっており、低分子APIのような生産に必要な原材料の需要が高まると予想されます。さらに、既存製品の強化に関連する技術の進歩は、低分子治療薬に新たな機会を提供すると期待されています。例えば、2022年3月、エボニックは経口低分子の溶解度を高める新しい技術「EUDRATECSoluFlow」を発売しました。

市場を牽引するのは、各地域、特にアジアにおいて、合成低分子APIの生産を原薬供給に依存する原薬メーカーが大半を占める中、原薬生産に対する政府の積極的な支援です。原薬製造のアウトソーシング活動への注目も高まっています。例えば、2020年4月、COVID-19を管理するために、波長製薬は呼吸器重症患者の管理に必要な特定の医薬品の主要薬効成分の供給を拡大し、API CDMOサービスを開始しました。中国、インド、東南アジアなどの新興市場は、大きな成長機会となっています。

アジアのメーカーは、大量生産が可能なあまり複雑でない分子に重点を置いているため、新しく複雑な技術への投資は比較的低水準にとどまっています。したがって、欧州や北米などの他の先進地域のメーカーにとって、高収率かつ低コストの技術への投資は、競合の圧力を回避するための選択肢となります。

市場で事業を展開する主要企業は、強力なAPI製品の生産に向けた連携に注力しています。例えば、2021年8月、Almac SciencesはPila Pharmaと、高活性かつ選択的な低分子TRPV1アンタゴニストであるAPI XEN-D0501の生産のための契約を締結しました。さらに、CDMOは合成医薬品の需要の高まりに対応するため、能力を拡大することで常に進化を続けています。例えば、2022年4月、AGC Inc.はスペインの施設を合成医薬品生産用に7500m2拡張することを発表し、同地域の合成低分子APIの需要拡大が期待されています。

合成低分子API市場レポートハイライト

市場全体の成長は、原料需要の増加に伴う医薬品生産の増加によるものです。

API市場は、合成低分子APIの大量生産を行うCDMOへの嗜好が高まり、重要な転換期を迎えている

メーカー別では、中小企業が商業生産を外注に依存していることから、外注分野が予測期間中に大きな成長を遂げると予想される

2021年の市場セグメンテーションは、循環器領域が大半を占めました。これは、対象疾患の有病率が増加していることに起因する

主要企業の存在と、同地域のAPI製造能力を強化するための政府からの支援強化により、2021年には北米が市場を独占した

目次

第1章 合成低分子API市場：調査手法と範囲

• 市場セグメンテーション
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国ごとの市場予測
    • アプローチ2：トップダウンアプローチを使用した国ごとの市場推定
• 世界市場：CAGR計算
• 地域市場：CAGR計算
• 二次情報のリスト
• 目的
• 略語一覧

第2章 合成低分子API市場：エグゼクティブサマリー

• 合成低分子API市場：市場の見通し
  • 市場概要

第3章 合成低分子API市場：業界の展望

• 市場系列の見通し
  • 親市場系統の見通し
  • 関連/補助的な市場の見通し
• 浸透と成長の見通しのマッピング
• 市場力学
  • 市場促進要因
    • 製薬産業の高成長
    • 研究開発の増加と新規分子の発売
    • API生産のアウトソーシングの増加
    • 高齢者人口の増加
    • 慢性疾患の蔓延
  • 市場抑制要因分析
    • 生物製剤の出現
    • アジア諸国への生産依存度が高い
• SWOT分析：要因別（政治と法律、経済と技術）
• 業界分析：ポーターズ
• 償還と規制のシナリオ
• 主要取引と戦略的提携
  • 新製品の発売
  • 取得
  • 拡張
  • パートナーシップ
  • マーケティングとプロモーション

第4章 合成低分子API市場：競合情勢

• 最近の動向と影響分析：主要な市場参入企業別
  • Ansoff Matrix
• 会社の分類
  • イノベーター
    • 市場の差別化要因
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2021年
• 公開会社
  • 競合ダッシュボード分析
• 非公開会社
  • 主要な新興企業のリスト
• Regional Network Map

第5章 合成低分子API市場：メーカーのビジネス分析

• 合成低分子API市場：メーカー変動分析
• 社内
• 外部委託

第6章 合成低分子API市場：アプリケーションビジネス分析

• 合成低分子API市場：アプリケーションの変動分析
• 心臓病学
• 腫瘍学
• 中枢神経系および神経学
• 整形外科
• 内分泌学
• 呼吸器科
• 消化器科
• 腎臓学
• 眼科
• その他

第7章 合成低分子API市場：地域ビジネス分析

• 国別の市場シェア分析、2021年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 合成低分子API市場：企業プロファイリング

• 企業プロファイル
  • AbbVie, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Bristol-Myers Squibb Company
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Boehringer Ingelheim International GmbH
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Cipla Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Teva Pharmaceutical Industries Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Albemarle Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Viatris Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Aurobindo Pharma
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Sun Pharmaceutical Industries Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Dr. Reddy's Laboratories Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
• その他の主要な企業リスト

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Incidence of Diseases
• Table 4 Global Synthetic Small Molecule API Market, By Region, 2018 - 2030 (USD Billion)
• Table 5 Global Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 6 Global Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 7 North America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
• Table 8 North America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 9 North America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 10 U.S. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 11 U.S. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 12 Canada Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 13 Canada Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 14 Europe Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
• Table 15 Europe Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 16 Europe Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 17 Germany Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 18 Germany Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 19 U.K. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 20 U.K. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 21 France Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 22 France Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 23 Italy Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 24 Italy Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 25 Spain Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 26 Spain Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 27 Asia Pacific Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
• Table 28 Asia Pacific Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 29 Asia pacific Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 30 Japan Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 31 Japan Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 32 China Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 33 China Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 34 India Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 35 India Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 36 South Korea Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 37 South Korea Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 38 Australia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 39 Australia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 40 Latin America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
• Table 41 Latin America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 42 Latin America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 43 Brazil Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 44 Brazil Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 45 Mexico Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 46 Mexico Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 47 Argentina Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 48 Argentina Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 49 Middle East & Africa Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
• Table 50 Middle East & Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 51 Middle East & Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 52 Saudi Arabia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 53 Saudi Arabia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 54 South Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 55 South Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
• Table 56 UAE Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
• Table 57 UAE Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Synthetic small molecule API market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Synthetic Small Molecule API market snapshot
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Billion)
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Synthetic small molecule API market driver impact
• Fig. 14 Synthetic small molecule API market restraint impact
• Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 16 Industry Analysis - Porter's
• Fig. 17 Strategy mapping
• Fig. 18 Synthetic small molecule API market: manufacturer outlook and key takeaways
• Fig. 19 Synthetic small molecule API market: manufacturer movement analysis & market share 2021 & 2030
• Fig. 20 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 21 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 22 Synthetic small molecule API market: application outlook and key takeaways
• Fig. 23 Synthetic small molecule API market: application movement analysis & market share 2021 & 2030
• Fig. 24 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 25 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 26 CNS and Neurology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 27 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 28 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 29 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 30 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 31 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 32 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 34 Small Molecule API: Regional outlook and key takeaways
• Fig. 35 Regional outlook, 2021 & 2030
• Fig. 36 North America
• Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 38 U.S.
• Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 40 Canada
• Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 42 Europe
• Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 44 U.K.
• Fig. 45 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 46 Germany
• Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 48 France
• Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 50 Italy
• Fig. 51 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 52 Spain
• Fig. 53 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 54 Asia Pacific
• Fig. 55 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 56 Japan
• Fig. 57 Japan market estimates and forecast, 2018 - 2030(USD Billion)
• Fig. 58 China
• Fig. 59 China market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 60 India
• Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 62 South Korea
• Fig. 63 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 64 Australia
• Fig. 65 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 66 Latin America
• Fig. 67 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 68 Brazil
• Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 70 Mexico
• Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 72 Argentina
• Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 74 Middle East & Africa
• Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 76 South Africa
• Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 78 Saudi Arabia
• Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 80 UAE
• Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 82 Ansoff Matrix
• Fig. 83 Market differentiators
• Fig. 84 Key company market share analysis, 2021
• Fig. 85 Company market position analysis
• Fig. 86 Competitive dashboard analysis
• Fig. 87 Regional network map

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is expected to reach USD 217.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.73% from 2022 to 2030. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

• The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material

• The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk

• By manufacturer, the outsourced segment is expected to witness lucrative growth over the forecast period owing to a dependency of small and mid-sized companies on outsourcing for commercial production

• The cardiology appolication segment dominated the market in 2021. This is attributed to the increasing prevalence of target diseases

• North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Table of Contents

Chapter 1 Synthetic Small Molecule API Market: Methodology And Scope

• 1.1 Market Segmentation
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
    • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Regional Market: CAGR Calculation
• 1.9 List Of Secondary Sources
• 1.10 Objectives
  • 1.10.1 Objective 1:
  • 1.10.2 Objective 2:
• 1.11 List of Abbreviations

Chapter 2 Synthetic Small Molecule API Market: Executive Summary

• 2.1 Synthetic Small Molecule API Market: Market Outlook
  • 2.1.1 Market Summary

Chapter 3 Synthetic Small Molecule API Market: Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Lineage Outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Drivers
    • 3.3.1.1 High growth of the pharmaceutical industry
    • 3.3.1.2 Rising R&D and launch of novel molecules
    • 3.3.1.3 Increased outsourcing of API production
    • 3.3.1.4 Growing geriatric population
    • 3.3.1.5 Escalating prevalence of chronic diseases
  • 3.3.2 Market restraint Analysis
    • 3.3.2.1 Emergence of biologics
    • 3.3.2.2 High dependence on Asian nations for production
• 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• 3.5 Industry Analysis - Porter's
• 3.6 Reimbursement & Regulatory Scenario
• 3.7 Major Deals & Strategic Alliances
  • 3.7.1 New Product Launch
  • 3.7.2 Acquisition
  • 3.7.3 Expansion
  • 3.7.4 Partnerships
  • 3.7.5 Marketing & Promotions

Chapter 4 Synthetic Small Molecule API Market: Competitive Landscape

• 4.1 Recent developments & impact analysis, by key market participants
  • 4.1.1 Ansoff Matrix
• 4.2 Company Categorization
  • 4.2.1 Innovators
    • 4.2.1.1 Market Differentiators
• 4.3 Vendor Landscape
  • 4.3.1 List Of Key Distributors And Channel Partners
  • 4.3.2 Key Customers
  • 4.3.3 Key Company Market Share Analysis, 2021
• 4.4 Public Companies
  • 4.4.1 Competitive Dashboard Analysis
• 4.5 Private Companies
  • 4.5.1 List Of Key Emerging Companies
• 4.6 Regional Network Map

Chapter 5 Synthetic Small Molecule API Market: Manufacturer Business Analysis

• 5.1 Synthetic Small Molecule API Market: Manufacturer Movement Analysis
• 5.2 In-house
  • 5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion) (Volume, in Metric Tons)
• 5.3 Outsourced
  • 5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)(Volume, in Metric Tons)

Chapter 6 Synthetic Small Molecule API Market: Application Business Analysis

• 6.1 Synthetic Small Molecule API Market: Application Movement Analysis
• 6.2 Cardiology
  • 6.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.3 Oncology
  • 6.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.4 CNS and Neurology
  • 6.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.5 Orthopedic
  • 6.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.6 Endocrinology
  • 6.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.7 Pulmonology
  • 6.7.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.8 Gastroenterology
  • 6.8.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.9 Nephrology
  • 6.9.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.10 Opthalmology
  • 6.10.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
• 6.11 Others
  • 6.11.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7 Synthetic Small Molecule API Market: Regional Business Analysis

• 7.1 Market Share Analysis by Country, 2021 & 2030
  • 7.1.1 North America
    • 7.1.1.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.1.2 U.S.
    • 7.1.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.1.3 Canada
    • 7.1.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.1.2 Europe
    • 7.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2.2 U.K.
    • 7.1.2.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2.3 Germany
    • 7.1.2.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2.4 France
    • 7.1.2.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2.5 Italy
    • 7.1.2.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2.6 Spain
    • 7.1.2.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.1.3 Asia Pacific
    • 7.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3.2 Japan
    • 7.1.3.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3.3 China
    • 7.1.3.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3.4 India
    • 7.1.3.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3.5 South Korea
    • 7.1.3.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3.6 Australia
    • 7.1.3.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.1.4 Latin America
    • 7.1.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4.2 Brazil
    • 7.1.4.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4.3 Mexico
    • 7.1.4.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4.4 Argentina
    • 7.1.4.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.1.5 Middle East & Africa
    • 7.1.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5.2 South Africa
    • 7.1.5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5.3 Saudi Arabia
    • 7.1.5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5.4 UAE
    • 7.1.5.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Synthetic Small Molecule API Market: Company Profiling

• 8.1 Company Profiles
  • 8.1.1 AbbVie, Inc.
    • 8.1.1.1 Company overview
    • 8.1.1.2 Financial performance
    • 8.1.1.3 Product benchmarking
    • 8.1.1.4 Strategic initiatives
  • 8.1.2 Bristol-Myers Squibb Company
    • 8.1.2.1 Company overview
    • 8.1.2.2 Financial performance
    • 8.1.2.3 Product benchmarking
    • 8.1.2.4 Strategic initiatives
  • 8.1.3 Boehringer Ingelheim International GmbH
    • 8.1.3.1 Company overview
    • 8.1.3.2 Financial performance
    • 8.1.3.3 Product benchmarking
    • 8.1.3.4 Strategic initiatives
  • 8.1.4 Cipla Inc.
    • 8.1.4.1 Company overview
    • 8.1.4.2 Financial performance
    • 8.1.4.3 Product benchmarking
    • 8.1.4.4 Strategic initiatives
  • 8.1.5 Teva Pharmaceutical Industries Ltd.
    • 8.1.5.1 Company overview
    • 8.1.5.2 Financial performance
    • 8.1.5.3 Product benchmarking
    • 8.1.5.4 Strategic initiatives
  • 8.1.6 Albemarle Corporation
    • 8.1.6.1 Company overview
    • 8.1.6.2 Financial performance
    • 8.1.6.3 Product benchmarking
    • 8.1.6.4 Strategic initiatives
  • 8.1.7 Viatris Inc.
    • 8.1.7.1 Company overview
    • 8.1.7.2 Financial performance
    • 8.1.7.3 Product benchmarking
    • 8.1.7.4 Strategic initiatives
  • 8.1.8 Aurobindo Pharma
    • 8.1.8.1 Company overview
    • 8.1.8.2 Financial performance
    • 8.1.8.3 Product benchmarking
    • 8.1.8.4 Strategic initiatives
  • 8.1.9 Sun Pharmaceutical Industries Ltd.
    • 8.1.9.1 Company overview
    • 8.1.9.2 Financial performance
    • 8.1.9.3 Product benchmarking
    • 8.1.9.4 Strategic initiatives
  • 8.1.10 Dr. Reddy's Laboratories Ltd.
    • 8.1.10.1 Company overview
    • 8.1.10.2 Financial performance
    • 8.1.10.3 Product benchmarking
    • 8.1.10.4 Strategic initiatives
• 8.2 List of Other Key Players